 CAMBRIDGE, Mass.--BUSINESS WIRE--2seventy bio, Inc. Nasdaq: TSVT, a leading immuno-oncology cell therapy company, announced today that members of the management team will participate in the following upcoming investor conferences: 17th Annual Citi BioPharma Conference, Cell Therapy Part 1 panel on Wednesday, September 7, 2022 at 9:40am ET in Boston, MA 2022 Morgan Stanley Global Healthcare Conference, fireside chat on Wednesday, September 14, 2022 at 11:45am ET in New York, NY Live webcas 